Caitong International Asset Management »

Sab Biotherapeutics shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $617 161 3.83

More positions owned by Caitong International Asset Management

Lumentum Hldgs (LITE)
Axt (AXTI)
Venture Global Com Cl A (VG)
Marvell Technology (MRVL)
Palantir Technologies Cl A (PLTR)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Exxon Mobil Corporation (XOM)
CF Industries Holdings (CF)
Cheniere Energy Com New (LNG)
Petroleo Brasileiro S A Sp Adr Non Vtg (PBR.A)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
SLB Com Stk (SLB)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Caitong International Asset Management

Top funds holding Sab Biotherapeutics

Vivo Capital
Perceptive Advisors
Commodore Capital
RA Capital Management
Balyasny Asset Management
Millennium Management
Woodline Partners
Vanguard Capital Management
Sessa Capital IM
Vanguard Group
Boothbay Fund Management
Ameriprise Financial
Ensign Peak Advisors
Soleus Capital Management
Propel Bio Management

View all funds holding Sab Biotherapeutics